Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Relief Therapeutics
Sort By
Newest First
1 / 1
1 / 1
COVID-19 Clinical Trials
NeuroRx and Relief Therapeutics Announce Continuation of RLF-100 Trial for the Treatment of COVID-19 Respiratory Failure
NeuroRx
PR-M11-20-005
Nov 06, 2020
Divestment
RELIEF THERAPEUTICS Holding SA Announces Divestment of its Subsidiary Relief Therapeutics SA to Sonnet BioTherapeutics, Inc.
RELIEF THERAPEUTICS Holding SA
PR-M08-19-NI-046
Aug 16, 2019
